Slamming the door on unwanted guests: Why preemptive strikes at the mucosa may be the best strategy against HIV

Journal of Leukocyte Biology

Volumn 80, Issue 5, 2006, Pages 1076-1083

  Trapp, Susanna ^a   Turville, Stuart G ^a   Robbiani, Melissa ^a  

^a POPULATION COUNCIL   (United States)

Author keywords

Dendritic cells; Macrophage; Microbicide; Transmission

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 4 BENZOYL 1 [(4 METHOXY 1H PYRROLO[2,3 B]PYRIDIN 3 YL)OXOACETYL] 2 METHYLPIPERAZINE; ACID; ALEMTUZUMAB; BENZALKONIUM CHLORIDE; BETA CYCLODEXTRIN; BUFFER; CELLULOSE ACETATE; CELLULOSE SULFATE; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CMPD 167; CYANOVIRIN N; DAPIVIRINE; EFAVIRENZ; ENFUVIRTIDE; ESTROGEN; GLYCAN; MANNAN; MICROBICIDE; MIV 150; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; NAPHTHALENE DERIVATIVE; PC 815; POLYANION; POLYSTYRENE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SPL 7013; SURFACTANT; TENOFOVIR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CD4+ T LYMPHOCYTE; CLINICAL TRIAL; DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LAMINA PROPRIA; MEMBRANE PERMEABILITY; MUCOSA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SQUAMOUS EPITHELIUM; VIRION; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALS; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, IMMUNOLOGICAL; MUCOUS MEMBRANE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750441526     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0206121     Document Type: Review

References (68)

1. Wira, C. R., Fahey, J. V., Sentman, C. L., Pioli, P. A., Shen, L. (2005) Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 206, 306-335.
2. Smith, S. M., Mefford, M., Sodora, D., Klase, Z., Singh, M., Alexander, N., Hess, D., Marx, P. A. (2004) Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 18, 1637-1643.
3. Haase, A. T. (2005) Perils at mucosal front lines for HIV and SIV and their hosts. Nat. Rev. Immunol. 5, 783-792.
4. Miller, C. J., Li, Q., Abel, K., Kim, E. Y., Ma, Z. M., Wietgrefe, S., La Franco-Scheuch, L., Compton, L., Duan, L., Shore, M. D., Zupancic, M., Busch, M., Carlis, J., Wolinsky, S., Haase, A. T. (2005) Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79, 9217-9227.
5. Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., Shaw, G. M., Korber, B. T., Allen, S., Hunter, E. (2004) Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303, 2019-2022.
6. Zhang, Z. Q., Wietgrefe, S. W., Li, Q., Shore, M. D., Duan, L., Reilly, C., Lifson, J. D., Haase, A. T. (2004) Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 101, 5640-5645.
7. Maher, D., Wu, X., Schacker, T., Horbul, J., Southern, P. (2005) HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc. Natl. Acad. Sci. USA 102, 11504-11509.
8. Wu, Z., Chen, Z., Phillips, D. M. (2003) Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ cells: implications for mechanisms of sexual transmission. J. Infect. Dis. 188, 1473-1482.
9. Maher, D., Wu, X., Schacker, T., Larson, M., Southern, P. (2004) A model system of oral HIV exposure, using human palatine tonsil, reveals extensive binding of HIV infectivity, with limited progression to primary infection. J. Infect. Dis. 190, 1989-1997.
10. De Clercq, E. (2005) Emerging anti-HIV drugs. Expert Opin. Emerg. Drugs 10, 241-273.
11. Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J. P., Ricciardi-Castagnoli, P. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2, 361-367.
12. Frank, I., Piatak, M. J., Stoessel, H., Romani, N., Bonnyay, D., Lifson, J. D., Pope, M. (2002) Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. J. Virol. 76, 2936-2951.
13. Cameron, P. U., Freudenthal, P. S., Barker, J. M., Gezelter, S., Inaba, K., Steinman, R. M. (1992) Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257, 383-387.
14. Blauvelt, A., Asada, H., Saville, M. W., Klaus-Kovtun, V., Altman, D. J., Yarchoan, R., Katz, S. I. (1997) Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J. Clin. Invest. 100, 2043-2053.
15. Turville, S. G., Santos, J. J., Frank, I., Cameron, P. U., Wilkinson, J., Miranda-Saksena, M., Dable, J., Stoessel, H., Romani, N., Piatak, M., Lifson, J. D., Pope, M., Cunningham, A. L. (2004) Immunodeficiency virus uptake, turnover and two phase transfer in human dendritic cells. Blood 103, 2170-2179.
16. Teleshova, N., Frank, I., Pope, M. (2003) Immunodeficiency virus exploitation of dendritic cells in the early steps of infection. J. Leukoc. Biol. 74, 683-690.
17. Turville, S. G., Cameron, P. U., Hart, D., Cunningham, A. L. (2002) C-type lectin-HIV attachment on dendritic cells: innate immune recognition and processing or mediators of HIV transmission? Trends Glycosci. Glycotechnol. 14, 255-271.
18. Nguyen, D. G., Hildreth, J. E. (2003) Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33, 483-493.
19. Moore, J. S., Rahemtulla, F., Kent, L. W., Hall, S. D., Ikizler, M. R., Wright, P. F., Nguyen, H. H., Jackson, S. (2003) Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro. Virology 313, 343-353.
20. Spira, A. I., Marx, P. A., Patterson, B. K., Mahoney, J., Koup, R. A., Wolinsky, S. M., Ho, D. D. (1996) Cellular targets of infection and route 1 of viral dissemination following an intravaginal inoculation of SIV into rhesus macaques. J. Exp. Med. 183, 215-225.
21. Hu, J., Gardner, M. B., Miller, C. J. (2000) Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74, 6087-6095.
22. Turville, S. G., Vermeire, K., Balzarini, J., Schols, D. (2005) Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic cell-directed HIV-1 transfer. J. Virol. 79, 13519-13527.
23. Willey, R. L., Shibata, R., Freed, E. O., Cho, M. W., Martin, M. A. (1996) Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J. Virol. 70, 6431-6436.
24. Frank, I., Kacani, L., Stoiber, H., Stössel, H., Spruth, M., Steindl, F., Romani, N., Dierich, M. P. (1999) Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. J. Virol. 73, 3449-3454.
25. Latif, A. S., Katzenstein, D. A., Bassett, M. T., Houston, S., Emmanuel, J. C., Marowa, E. (1989) Genital ulcers and transmission of HIV among couples in Zimbabwe, AIDS 3, 519-523.
26. Guenthner, P. C., Secor, W. E., Dezzutti, C. S. (2005) Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect. Immun. 73, 4155-4160.
27. Levine, W. C., Pope, V., Bhoomkar, A., Tambe, P., Lewis, J. S., Zaidi, A. A., Farshy, C. E., Mitchell, S., Talkington, D. F. (1998) Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J. Infect. Dis. 177, 167-174.
28. Mikloska, Z., Bosnjak, L., Cunningham, A. L. (2001) Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75, 5958-5964.
29. Salio, M., Cella, M., Suter, M., Lanzavecchia, A. (1999) Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29, 3245-3253.
30. Pollara, G., Speidel, K., Samady, L., Rajpopat, M., McGrath, Y., Ledermann, J., Coffin, R. S., Katz, D. R., Chain, B. (2003) Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J. Infect. Dis. 187, 165-178.
31. Larsson, M. (2005) HIV-1 and the hijacking of dendritic cells: a tug of war. Springer Semin. Immunopathol. 26, 309-328.
32. Messmer, D., Ignatius, R., Santisteban, C., Steinman, R. M., Pope, M. (2000) The decreased replicative capacity of SIV mac239 Δ Nef is manifest in cultures of immature dendritic cells and T cells. J. Virol. 74, 2406-2413.
33. Fackler, O. T., Wolf, D., Weber, H. O., Laffert, B., D'Aloja, P., Schuler-Thurner, B., Geffin, R., Saksela, K., Geyer, M., Peterlin, B. M., Schuler, G., Baur, A. S. (2001) A natural variability in the praline-rich motif of Nef modulates HIV-1 replication in primary T cells. Curr. Biol. 11, 1294-1299.
34. Krautkramer, E., Giese, S. I., Gasteier, J. E., Muranyi, W., Fackler, O. T. (2004) Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 78, 4085-4097.
35. Mann, J., Patrick, C. N., Cragg, M. S., Honeychurch, J., Mann, D. A., Harris, M. (2005) Functional analysis of HIV type 1 Nef reveals a role for PAK2 as a regulator of cell phenotype and function in the murine dendritic cell line, DC2.4. J. Immunol. 175, 6560-6569.
36. Messmer, D., Jacqué, J-M., Santisteban, C., Bristow, C., Han, S-Y., Villamide-Herrera, L., Mehlhop, E., Marx, P. A., Steinman, R. M., Gettie, A., Pope, M. (2002) Nef uncouples dendritic cell phenotypic maturation from cytokine and chemokine secretion. J. Immunol. 169, 4172-4182.
37. Messmer, D., Bromberg, J., Devgan, G., Jacqué, J-M., Granelli-Piperno, A., Pope, M. (2002) Human immunodeficiency virus type 1 Nef mediates activation of STAT3 in immature dentritic cells. AIDS Res. Hum. Retroviruses 18, 1043-1050.
38. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P., Steinman, R. M. (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. USA 101, 7669-7674.
39. Takeda, K., Kaisho, T., Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376.
40. Schaefer, T. M., Fahey, J. V., Wright, J. A., Wira, C. R. (2005) Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J. Immunol. 174, 992-1002.
41. Fichorova, R. N., Cronin, A. O., Lien, E., Anderson, D. J., Ingalls, R. R. (2002) Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling. J. Immunol. 168, 2424-2432.
42. Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A. M., Hartmann, G. (2001) Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026-3037.
43. Kopp, E., Medzhitov, R. (2003) Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15, 396-401.
44. Wang, Y., Abel, K., Lantz, K., Krieg, A. M., McChesney, M. B., Miller, C. J. (2005) The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J. Virol. 79, 14355-14370.
45. Sanghavi, S. K., Reinhart, T. A. (2005) Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J. Immunol. 175, 5314-5323.
46. Van Damme, L., Ramjee, G., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., Sirivongrangson, P., Mukenge-Tshibaka, L., Ettiegne-Traore, V., Uaheowitchai, C., Karim, S. S., Masse, B., Perriens, J., Laga, M. (2002) Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial. Lancet 360, 971-977.
47. Mauck, C. K., Creinin, M. D., Barnhart, K. T., Ballagh, S. A., Archer, D. F., Callahan, M. M., Schmitz, S. W., Bax, R. (2004) A phase I comparative postcoital testing study of three concentrations of C31G. Contraception 70, 227-231.
48. Graham, D. R., Chertova, E., Hilburn, J. M., Arthur, L. O., Hildreth, J. E. (2003) Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with β-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J. Virol. 77, 8237-8248.
49. Khanna, K. V., Whaley, K. J., Zeitlin, L., Moench, T. R., Mehrazar, K., Cone, R. A., Liao, Z., Hildreth, J. E., Hoen, T. E., Shultz, L., Markham, R. B. (2002) Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J. Clin. Invest. 109, 205-211.
50. Moulard, M., Lortat-Jacob, H., Mondor, I., Roca, G., Wyatt, R., Sodroski, J., Zhao, L., Olson, W., Kwong, P. D., Sattentau, Q. J. (2000) Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74, 1948-1960.
51. Boadi, T., Schneider, E., Chung, S., Tsai, L., Gettie, A., Ratterree, M., Blanchard, J., Neurath, A. R., Cheng-Mayer, C. (2005) Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus. AIDS 19, 1587-1594.
52. Weber, J., Nunn, A., O'Connor, T., Jeffries, D., Kitchen, V., McCormack, S., Stott, J., Almond, N., Stone, A., Darbyshire, J. (2001) "Chemical condoms" for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo. AIDS 15, 1563-1568.
53. Fernández-Romero, J. A., Thorn, M., Titchen, K., Sudol, K., Li, J., Turville, S. G., Miller, T., Robbiani, M., Maguire, R. A., Buckheit, R. W., Hartman, T. L., Phillips, D. M. (2006) Carrageenan/MIV-150 (PC-815), a combination microbicide. Sex. Transm. Dis.
54. Baba, M., Snoeck, R., Pauwels, R., de Clercq, E. (1988) Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob. Agents Chemother. 32, 1742-1745.
55. Zacharopoulos, V. R., Phillips, D. M. (1997) Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin. Diagn. Lab. Immunol. 4, 465-468.
56. American Health Consultants. (2000) Microbicides, vaccines will cut unintended pregnancies and STDs. Contracept. Technol. Update 21, 1-3.
57. Bolmstedt, A. J., O'Keefe, B. R., Shenoy, S. R., McMahon, J. B., Boyd, M. R. (2001) Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol. Pharmacol. 59, 949-954.
58. Tsai, C. C., Emau, P., Jiang, Y., Agy, M. B., Shattock, R. J., Schmidt, A., Morton, W. R., Gustafson, K. R., Boyd, M. R. (2004) Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res. Hum. Retroviruses 20, 11-18.
59. Veazey, R. S., Shattock, R. J., Pope, M., Kirijan, J. C., Jones, J., Hu, Q., Ketas, T., Marx, P. A., Klasse, P. J., Burton, D. R., Moore, J. P. (2003) Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9, 343-346.
60. Veazey, R. S., Klasse, P. J., Schader, S. M., Hu, Q., Ketas, T. J., Lu, M., Marx, P. A., Dufour, J., Colonno, R. J., Shattock, R. J., Springer, M. S., Moore, J. P. (2005) Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438, 99-102.
61. Hu, Q., Frank, I., Williams, V., Santos, J. J., Watts, P., Griffin, G. E., Moore, J. P., Pope, M., Shattock, R. J. (2004) Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 199, 1065-1075.
62. Judice, J. K., Tom, J. Y., Huang, W., Wrin, T., Vennari, J., Petropoulos, C. J., McDowell, R. S. (1997) Inhibition of HIV type 1 infectivity by constrained α-helical peptides: implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. USA 94, 13426-13430.
63. Kilby, J. M., Lalezari, J. P., Eron, J. J., Carlson, M., Cohen, C., Arduino, R. C., Goodgame, J. C., Gallant, J. E., Volberding, P., Murphy, R. L., Valentine, F., Saag, M. S., Nelson, E. L., Sista, P. R., Dusek, A. (2002) The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res. Hum. Retroviruses 18, 685-693.
64. Rao, S., Hu, S., McHugh, L., Lueders, K., Henry, K., Zhao, Q., Fekete, R. A., Kar, S., Adhya, S., Hamer, D. H. (2005) Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc. Natl. Acad. Sci. USA 102, 11993-11998.
65. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., Landau, N. R. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377.
66. Lederman, M. M., Veazey, R. S., Offord, R., Mosier, D. E., Dufour, J., Mefford, M., Piatak Jr., M., Lifson, J. D., Salkowitz, J. R., Rodriguez, B., Blauvelt, A., Hartley, O. (2004) Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306, 485-487.
67. Hossain, M. M., Parniak, M. A. (2006) In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1. J. Virol. 80, 4440-4446.
68. Towie, N. (2005) Drug firms donate compounds for anti-HIV gel. Nature 438, 6-7.